Evidence-Based · Doctor-Reviewed · No Grey Market BS
Get the Weekly Brief
performance

Peptides for Cognitive Function: What Works

Evidence-based guide to peptides for cognitive function — Semax, Selank, Dihexa, and BPC-157 reviewed for memory, focus, neuroprotection, and brain health.

By Pure Peptide Clinic Editorial Team · Reviewed by Dr. Javed Iqbal, MBBS · Updated 2026-03-11

Your brain runs on chemistry. Neurotransmitters, growth factors, and signaling molecules dictate how well you focus, how quickly you recall information, and how clearly you think under stress. When these systems decline — from aging, chronic stress, poor sleep, or neurological injury — cognitive performance drops.

Certain peptides can modulate these systems directly. Some upregulate BDNF, the growth factor your brain needs to form new connections. Others adjust GABA transmission to reduce anxiety without the fog of benzodiazepines. A few promote actual synaptogenesis — the formation of new synapses between neurons.

But the evidence varies widely. Some cognitive peptides have decades of clinical use behind them. Others are promising in rodent models but unproven in humans. This guide separates what’s supported from what’s speculative, so you can make informed decisions with your prescribing provider. For a broader overview of peptide therapy and how peptides work, start there.

Key Takeaways

  • Semax has the strongest clinical track record — approved in Russia for cognitive disorders since 2011, with documented BDNF upregulation in human and animal studies
  • Selank combines cognitive enhancement with anxiety reduction through GABA modulation, without sedation or dependency
  • Dihexa shows extraordinary potency in preclinical models (10 million times more potent than BDNF in some assays) but has no human clinical trials
  • BPC-157 has emerging neuroprotective data that extends beyond its well-known role in gut and tissue repair

Table of Contents

How Peptides Affect Brain Function

Cognitive peptides work through several mechanisms:

Neurotrophic factor modulation. BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) are proteins that support neuron survival, growth, and plasticity. Higher BDNF levels correlate with better memory formation, faster learning, and protection against neurodegenerative disease. Several peptides — particularly Semax — directly increase BDNF expression in the hippocampus and frontal cortex [1].

Neurotransmitter regulation. Peptides like Selank modulate GABA, serotonin, and dopamine pathways. Unlike pharmaceutical anxiolytics that broadly dampen brain activity, these peptides fine-tune specific neurotransmitter systems [2].

Synaptogenesis. Some peptides promote the formation of new synaptic connections. More synapses mean more pathways for information processing — effectively expanding your brain’s wiring capacity.

Neuroprotection. Certain peptides protect existing neurons from oxidative stress, inflammation, and excitotoxicity — processes that accelerate cognitive decline with age.

Different types of peptides target these pathways in different ways, which is why stacking complementary compounds can produce broader cognitive benefits than any single peptide alone. For ranked stacking options, see our best peptide stack guide.

Semax — The Most Studied Cognitive Peptide

Evidence Rating: Strong (clinical use in Russia since 2011)

Semax is a synthetic analog of ACTH(4-10), the fragment of adrenocorticotropic hormone involved in attention and memory. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been approved in Russia for over a decade to treat cognitive disorders, stroke recovery, and optic nerve disease.

Mechanism

Semax rapidly increases BDNF and trkB (its receptor) expression in the hippocampus — the brain region most directly involved in memory formation and learning [1]. A separate study showed it also upregulates NGF expression in the frontal cortex, with effects lasting at least 8 hours after a single dose [3]. The BDNF and NGF pathways Semax targets are also central to mood regulation, which is why it’s relevant in discussions about peptides for depression.

Beyond neurotrophic factors, Semax increases serotonin levels and potentiates the stimulatory effects of dopaminergic compounds [4]. It also has documented anti-inflammatory effects in neural tissue, reducing pro-inflammatory cytokines that contribute to cognitive decline.

What the Clinical Data Shows

In studies of stroke patients, Semax improved cognitive recovery scores when added to standard treatment protocols [5]. A study with 8 patients showed measurable improvement in cognitive function after a single dose, and MRI-based studies with 24 subjects showed enhanced brain activity patterns.

In healthy animal models, both intranasal and intraperitoneal Semax improved performance on passive avoidance tests — a standard measure of learning and memory [4].

Dosing

  • Route: Intranasal (nasal spray)
  • Dose: 200–600 mcg per day, split into 1–2 administrations
  • Timing: Morning or early afternoon (can be mildly stimulating)
  • Cycle: 10–20 day courses, with 2-week breaks between

Who It’s Best For

  • Professionals needing sustained focus and mental clarity
  • Age-related cognitive decline
  • Post-concussion or post-stroke cognitive recovery (under medical supervision)
  • Students or high-performers during demanding periods

Selank — Anxiety Reduction Meets Mental Clarity

Evidence Rating: Moderate-Strong (approved in Russia; extensive preclinical data)

Selank is a synthetic analog of the immunomodulatory peptide tuftsin. It occupies an interesting niche: it’s both a nootropic and an anxiolytic, reducing anxiety while simultaneously improving cognitive performance. That combination is rare — most anxiety medications impair cognition.

Mechanism

Selank modulates GABA-A receptor activity, producing anxiolytic effects comparable to benzodiazepines but without sedation, tolerance, or withdrawal [2]. It also influences enkephalin metabolism, stabilizing the brain’s endogenous opioid system without producing euphoria or dependency [6].

On the cognitive side, a 2003 study showed Selank “significantly activated the learning process in rats with initially poor learning ability,” with effects appearing after just one dose [7]. A 2008 study demonstrated its influence on motivational mechanisms through the noradrenergic system [8].

What Sets It Apart

The anxiolytic-nootropic combination is Selank’s defining feature. Anxiety is one of the biggest cognitive performance killers — it fragments attention, impairs working memory, and disrupts decision-making. By reducing anxiety without the cognitive dulling of traditional anxiolytics, Selank removes a major barrier to mental performance. If anxiety is a significant factor in your cognitive struggles, our guide to peptides for anxiety covers the full range of options beyond Selank.

Dosing

  • Route: Intranasal
  • Dose: 200–400 mcg per day, split into 1–2 administrations
  • Timing: Morning or as needed for anxiety-inducing situations
  • Cycle: 14-day courses, 2-week breaks

Who It’s Best For

  • High-anxiety individuals who need cognitive performance (presentations, exams, high-stakes work)
  • People with generalized anxiety who want to avoid benzodiazepine side effects
  • Those seeking both mood stabilization and mental clarity

Dihexa — Powerful but Unproven in Humans

Evidence Rating: Preclinical only (no human trials)

Dihexa generates attention because of one extraordinary data point: in assays of neurotrophic activity, it was found to be approximately seven orders of magnitude (10 million times) more potent than BDNF at promoting synaptogenesis [9]. That’s a staggering number. It’s also why this peptide demands honest context.

Mechanism

Dihexa is a hexapeptide derived from angiotensin IV. It activates the hepatocyte growth factor (HGF)/c-Met receptor system, which drives synaptogenesis — the creation of new connections between neurons [9].

In rodent hippocampal models, Dihexa exposure increased markers of synaptic density and structural plasticity. Rats treated with Dihexa showed improved performance in spatial learning tasks, even when their cognitive function had been artificially impaired [10].

The Honest Assessment

The preclinical potency is real and well-documented. But zero human clinical trials have been completed. We don’t know the human safety profile, optimal dosing, long-term effects, or whether the animal results translate to people.

Some peptide clinics prescribe Dihexa based on the preclinical promise and anecdotal patient reports. That’s a personal risk-benefit calculation you should make with a physician who’s transparent about the evidence gaps.

Dosing (Clinic Protocols — Not Clinically Validated)

  • Route: Subcutaneous injection or intranasal
  • Dose: 10–20 mg subcutaneous, or 5–10 mg intranasal
  • Timing: Morning
  • Cycle: 4–8 weeks, with breaks

Who Might Consider It

  • Patients with significant cognitive decline who’ve exhausted better-studied options
  • Those comfortable with the risk profile of a compound without human trial data
  • Under the care of a physician experienced with investigational peptides

BPC-157 — Neuroprotection Beyond Gut Healing

Evidence Rating: Moderate (strong preclinical, limited human data)

BPC-157 is best known for gut healing and tissue repair, but its neuroprotective properties are increasingly relevant to cognitive function discussions.

Mechanism

BPC-157 modulates dopaminergic, serotonergic, and GABAergic systems. Animal studies show it can counteract dopamine system disturbances caused by various toxins, protect against serotonin syndrome, and reduce anxiety-related behaviors [11].

It also promotes angiogenesis (new blood vessel formation), which is relevant to brain health — adequate cerebral blood flow is fundamental to cognitive function.

Cognitive Relevance

While BPC-157 isn’t a primary nootropic, its neuroprotective and neurotransmitter-modulatory effects make it a reasonable addition to cognitive stacks. It’s particularly relevant for:

  • Patients with gut-brain axis dysfunction (the gut produces ~95% of your serotonin)
  • Recovery from traumatic brain injury
  • Protection of cognitive function during periods of high stress

Read our full BPC-157 guide and BPC-157 dosing guide for detailed protocols. For the gut-brain connection specifically, see peptides for gut health.

Dosing for Cognitive Support

  • Route: Subcutaneous injection or oral
  • Dose: 250–500 mcg, 1–2x daily
  • Compare administration routes in our BPC-157 oral vs injection guide

The Semax + Selank Stack

This is the most popular cognitive peptide combination, and the logic is sound: Semax provides the cognitive acceleration (BDNF upregulation, enhanced focus, memory support) while Selank provides the emotional regulation (anxiety reduction, mood stabilization) that allows you to actually use that cognitive boost.

Why It Works

Anxiety and cognition sit on opposite ends of a seesaw for many people. The sharper your focus, the more aware you become of stressors. The more anxious you are, the harder it is to focus. The Semax/Selank stack addresses both sides simultaneously.

Semax pushes BDNF and NGF production, priming your hippocampus for learning and memory formation. Selank calms the amygdala and modulates GABA, reducing the anxiety that fragments attention. Neither compound causes sedation, so the net effect is alert, calm, focused cognition.

Protocol

  • Semax: 200–400 mcg intranasal, morning
  • Selank: 200–400 mcg intranasal, morning (can add a second dose if afternoon anxiety is an issue)
  • Cycle: 2–3 weeks on, 2 weeks off
  • Can be combined with GH-releasing stacks like CJC-1295 + Ipamorelin for combined cognitive and physical benefits

For more on stacking strategies across all goals, see our best peptide stack ranked guide.

Other Peptides with Cognitive Effects

Several peptides not primarily categorized as nootropics still influence brain function:

CJC-1295 + Ipamorelin. GH elevation improves sleep quality, and deep sleep is when memory consolidation occurs. Better sleep = better cognitive performance the next day. Many patients on this stack report improved mental clarity as a secondary benefit. See our CJC-1295 + Ipamorelin guide.

Thymosin Beta-4 (TB-500). Has documented neuroprotective effects in animal models of traumatic brain injury and stroke. Its role in promoting cellular repair extends to neural tissue. Read our TB-500 guide.

GHK-Cu. Primarily known for skin and hair benefits, GHK-Cu also modulates gene expression in ways that may support neuroprotection and reduce neuroinflammation. See our GHK-Cu guide.

MOTS-c. The mitochondrial peptide’s role in cellular energy production extends to neurons, which are among the most metabolically demanding cells in the body. Improved mitochondrial function could support sustained cognitive performance.

NAD+ precursors. While not peptides, NAD therapy is frequently discussed alongside cognitive peptides. NAD+ is a coenzyme involved in cellular energy production and DNA repair, both relevant to brain aging.

Side Effects and Safety

Cognitive peptides generally have favorable safety profiles, but the evidence base varies by compound.

Semax:

  • Well-tolerated in over a decade of clinical use in Russia
  • Mild nasal irritation (intranasal route)
  • Occasional headache at higher doses
  • No documented dependency or withdrawal effects
  • Mild stimulating effect — avoid late-day dosing if sleep-sensitive

Selank:

  • Anxiolytic without sedation, tolerance, or withdrawal
  • Mild nasal irritation
  • Rare reports of fatigue at higher doses
  • No documented interaction with standard medications (though data is limited)

Dihexa:

  • No human safety data — this is the primary concern
  • Theoretical risk of excessive synaptogenesis or off-target growth factor activation
  • Should only be used under direct physician supervision

BPC-157:

  • Generally well-tolerated with a large preclinical safety database
  • Mild injection site discomfort
  • For full side effect data, see our peptide side effects guide

All cognitive peptides should be sourced through a peptide clinic or compounding pharmacy that provides third-party purity testing. Grey-market products carry contamination and dosing accuracy risks. See our guide on are peptides safe for sourcing considerations.

FAQ

What is the best peptide for memory and focus?

Semax has the strongest combined evidence for memory and focus enhancement. It upregulates BDNF in the hippocampus (memory formation) and modulates dopamine and serotonin pathways (attention and focus). If anxiety is a significant factor in your cognitive issues, the Semax + Selank combination addresses both.

Are cognitive peptides the same as nootropics?

Cognitive peptides are a subset of nootropics. The broader nootropic category includes synthetic drugs (racetams, modafinil), natural supplements (lion’s mane, bacopa), and peptides. Peptides are distinguished by their specificity — they target defined receptors and signaling pathways rather than broadly modulating neurotransmitter levels.

How quickly do cognitive peptides work?

Semax and Selank produce noticeable effects within 15–30 minutes of intranasal administration, with peak effects at 1–2 hours. These acute effects (improved focus, reduced anxiety) are distinct from the longer-term neuroplasticity benefits, which build over 2–4 weeks of consistent use as BDNF levels accumulate.

Can I combine cognitive peptides with other peptide stacks?

Yes. Semax and Selank (intranasal) can be used alongside injectable stacks like CJC-1295 + Ipamorelin or BPC-157 without interaction concerns based on available data. Many performance-oriented protocols combine cognitive peptides with GH-releasing or recovery stacks. See our best peptide stack guide for combination strategies.

Do I need a prescription for cognitive peptides?

In the United States, most injectable peptides require a prescription. Intranasal formulations of Semax and Selank exist in regulatory grey areas depending on how they’re classified. The safest approach is working with a peptide therapy clinic or online provider that prescribes through licensed compounding pharmacies. See our guide on how to get peptides prescribed.

Sources

  1. Dolotov OV, et al. “Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.” Brain Res. 2006;1117(1):54-60. PubMed

  2. Zozulya AA, et al. “The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.” Bull Exp Biol Med. 2001;131(4):315-317. PubMed

  3. Shadrina M, et al. “Effect of Semax on the temporary dynamics of BDNF and NGF gene expression in the rat hippocampus and frontal cortex.” Mol Biol. 2008;42(4):652-657. PubMed

  4. Eremin KO, et al. “Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.” Neurochem Res. 2005;30(12):1493-1500. PubMed

  5. Gusev EI, et al. “Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular pathology.” Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(2):35-40. PubMed

  6. Kozlovskii II, Danchev ND. “The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.” Neurosci Behav Physiol. 2003;33(7):639-643. PubMed

  7. Kozlovskaya MM, et al. “Selank significantly activated the learning process in rats with initially poor learning ability.” Vestnik RAMS. 2003;8:28-32.

  8. Semenova TP, et al. “Selank and its effect on motivational mechanisms in rats.” Bull Exp Biol Med. 2008;146(7):68-71. PubMed

  9. McCoy AT, et al. “Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.” J Pharmacol Exp Ther. 2013;344(1):141-154. PubMed

  10. Benoist CC, et al. “Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs.” J Pharmacol Exp Ther. 2011;339(1):35-44. PubMed

  11. Sikiric P, et al. “Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications.” Curr Neuropharmacol. 2016;14(8):857-865. PubMed

Get guides like this delivered weekly.

Evidence-based peptide research, protocol breakdowns, and provider reviews.

Get the Weekly Brief